Search research articles

Search research articles

Related Experiment Videos

Cisplatin triggers platelet activation.

G I Togna¹, A R Togna, M Franconi

¹Department of Human Physiology and Pharmacology, University of Rome "La Sapienza," Italy. tognagi@uniroma1.it

Thrombosis Research

|September 6, 2000

Summary

Cisplatin, an anticancer drug, increases human platelet reactivity, contributing to thrombotic complications. This study reveals cisplatin

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Interferon alpha in the treatment of chronic hepatitis C in children: a meta-analysis [correction of metanalysis].

Journal of viral hepatitis·2003

Same author

Pharmacoutilization and costs of osteoarthritis: changes induced by the introduction of a cyclooxygenase-2 inhibitor into clinical practice.

Rheumatology (Oxford, England)·2003

Same author

[Evaluation model of the effect of Rofecoxib on the co-prescription of gastroprotective agents observed during the treatment of osteoarthritis].

Reumatismo·2003

Same author

Clinical and economic outcomes of pneumonia in children: a longitudinal observational study in an Italian paediatric hospital.

Journal of evaluation in clinical practice·2002

Same author

Cocaine toxic effect on endothelium-dependent vasorelaxation: an in vitro study on rabbit aorta.

Toxicology letters·2001

Same author

Beta-lactam antibiotic-mediated changes in platelet reactivity and vascular endothelial functions.

Pharmacology & toxicology·2001

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Area of Science:

Oncology
Hematology
Pharmacology

Background:

Anticancer drugs, including cisplatin, are linked to thrombotic complications in cancer patients.
Reported events include thrombotic microangiopathy, myocardial infarction, and cerebrovascular thrombotic events associated with cisplatin treatment.

Purpose of the Study:

To investigate the in vitro effects of cisplatin on human platelet reactivity.
To elucidate the role of platelets in the pathogenesis of cisplatin-induced thrombotic complications.

Main Methods:

In vitro assessment of human platelet aggregation.
Measurement of thromboxane production in response to cisplatin.
Analysis of arachidonic acid metabolism pathways.

Main Results:

Cisplatin significantly increases human platelet reactivity, indicated by accelerated platelet aggregation.
Cisplatin enhances thromboxane production.
Platelet activation appears to involve arachidonic acid metabolism, potentially via phospholipase A(2).

Conclusions:

Cisplatin enhances platelet aggregation and thromboxane production.
Platelet activation by cisplatin may contribute to thrombotic complications during chemotherapy.
Understanding this mechanism aids in managing chemotherapy-related risks.

Related Experiment Videos